NEW YORK , OCT. 25, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF TRONOX HOLDINGS PLC (NYSE: TROX) BETWEEN FEBRUARY 12, 2025 AND JULY 30, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 3, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED TRONOX COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
TROX
• Oct. 25, 2025
WILMINGTON, DEL.--(BUSINESS WIRE)---- $INCY #ISAD2025--INCYTE ANNOUNCES NEW DATA FROM PHASE 3B TRUE-AD4 TRIAL OF OPZELURA® (RUXOLITINIB CREAM) IN ADULTS WITH MODERATE ATOPIC DERMATITIS.
INCY
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF VERA BRADLEY, INC. (NASDAQ: VRA) RESULTING FROM ALLEGATIONS THAT VERA BRADLEY MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
VRA
• Oct. 25, 2025
NEW YORK , OCT. 25, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF QUANTUM CORPORATION (NASDAQ: QMCO) BETWEEN NOVEMBER 15, 2024 AND AUGUST 18, 2025, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 3, 2025 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION FIRST FILED BY THE FIRM. SO WHAT: IF YOU PURCHASED QUANTUM CORPORATION SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
QMCO
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) BETWEEN MARCH 10, 2024 AND SEPTEMBER 29, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT DECEMBER 15, 2025 LEAD PLAINTIFF DEADLINE.
LAW
• Oct. 25, 2025
TORONTO , OCT. 25, 2025 /PRNEWSWIRE/ -- VISIONARY HOLDINGS INC. (NASDAQ: GV) ("VISIONARY" OR THE "COMPANY"), A PRIVATE EDUCATION SERVICE PROVIDER INTEGRATING TECHNOLOGY AND INNOVATION, TODAY ANNOUNCED THAT ON AUGUST 5, 2025, IT RECEIVED A NOTIFICATION LETTER FROM THE LISTING QUALIFICATIONS DEPARTMENT OF THE NASDAQ STOCK MARKET ("NASDAQ") INDICATING THAT THE COMPANY IS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1) DUE TO ITS DELAY IN FILING ITS ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED MARCH 31, 2025 (THE "FORM 20-F"). THE NASDAQ LETTER HAS NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMPANY'S COMMON SHARES ON THE NASDAQ CAPITAL MARKET.
GV
• Oct. 25, 2025
AUSTIN, MINN. , OCT. 25, 2025 /PRNEWSWIRE/ -- HORMEL FOODS SALES, LLC IS VOLUNTARILY RECALLING 215,258 CASES, OR 4,874,815 TOTAL POUNDS, OF HORMEL® FIRE BRAISEDTM ITEMS THAT HAVE AN ESTABLISHMENT NUMBER OF P-223 SENT TO FOODSERVICE OPERATORS THROUGHOUT THE UNITED STATES AS THEY MAY CONTAIN EXTRANEOUS METAL MATERIAL.
HRL
• Oct. 25, 2025
LFMD INVESTORS WITH LOSSES ENCOURAGED TO CONTACT HAGENS BERMAN BEFORE OCT. 27TH DEADLINE LFMD INVESTORS WITH LOSSES ENCOURAGED TO CONTACT HAGENS BERMAN BEFORE OCT. 27TH DEADLINE
LFMD
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZIONS BANCORPORATION, N.A. (NASDAQ: ZION, ZIONP) RESULTING FROM ALLEGATIONS THAT ZIONS BANCORPORATION MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
ZION
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN KBR TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED KBR SECURITIES BETWEEN MAY 6, 2025 AND JUNE 19, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL BRAGAR EAGEL & SQUIRE PARTNER BRANDON WALKER OR MARION PASSMORE DIRECTLY AT (212) 355-4648.
KBR
• Oct. 25, 2025
DEFENDANTS ALLEGEDLY LACKED PROPER CONTROLS OVER THIRD-PARTY MANUFACTURERS, OVERSTATING JASPER'S BUSINESS STRENGTH AND BRIQUILIMAB'S CLINICAL PROSPECTS.
JSPR
• Oct. 25, 2025
DEFENDANTS ALLEGEDLY OVERSTATED FORTINET'S PRODUCT REFRESH IMPACT AND HID LIMITS ON UPGRADES, MISLEADING INVESTORS AND CAUSING A SHARP STOCK DECLINE.
FTNT
• Oct. 25, 2025
DEFENDANTS ALLEGEDLY ENGAGED IN TAX FRAUD AND BRIBERY TO CONCEAL IT, UNDERSTATING LEGAL RISKS AND MISLEADING INVESTORS ABOUT THE COMPANY'S OPERATIONS.
RICK
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF JASPER THERAPEUTICS, INC. (NASDAQ: JSPR) BETWEEN NOVEMBER 30, 2023 AND JULY 3, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 18, 2025 LEAD PLAINTIFF DEADLINE.
JSPR
• Oct. 25, 2025
POSTER PRESENTED TODAY IN BOSTON SHOWS DIRECT ANTI-TUMOR ACTIVITY IN MESOTHELIOMA MODELS, REDUCED TUMOR PD-L1 ALONGSIDE DECREASED PCREB, AND STRONG TT-4 MONOTHERAPY ACTIVITY WITH ADDED BENEFIT IN ANTI-PD-1 COMBINATIONS; TT-4 REMAINS ON TRACK FOR Q1 2026 FIRST-PATIENT DOSING POSTER PRESENTED TODAY IN BOSTON SHOWS DIRECT ANTI-TUMOR ACTIVITY IN MESOTHELIOMA MODELS, REDUCED TUMOR PD-L1 ALONGSIDE DECREASED PCREB, AND STRONG TT-4 MONOTHERAPY ACTIVITY WITH ADDED BENEFIT IN ANTI-PD-1 COMBINATIONS; TT-4 REMAINS ON TRACK FOR Q1 2026 FIRST-PATIENT DOSING
ATON
• Oct. 25, 2025
SOUTH SAN FRANCISCO, CALIF., OCT. 25, 2025 (GLOBE NEWSWIRE) -- BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (“BBOT”) (NASDAQ: BBOT), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON RAS-PATHWAY MALIGNANCIES, TODAY ANNOUNCED NEW PRECLINICAL DATA SHOWING BBO-10203 SELECTIVELY AND SPECIFICALLY BLOCKS THE PHYSICAL INTERACTION BETWEEN RAS AND PI3KΑ, RESULTING IN THE INHIBITION OF RAS-DRIVEN PI3KΑ-AKT SIGNALING IN TUMORS WITHOUT THE RISK OF HYPERGLYCEMIA. IN ADDITION, COMBINATION ACTIVITY WITH BBOT'S KRASG12C ON/OFF INHIBITOR, BBO-8520, AND PANKRAS INHIBITOR, BBO-11818, WAS OBSERVED AT WELL TOLERATED DOSE LEVELS IN A PANEL OF KRAS MUTANT MODELS. THE DATA WERE PRESENTED AT THE 2025 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS.
BBOT
• Oct. 25, 2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (“KSF”) ARE INVESTIGATING THE PROPOSED SALE OF MIDWESTONE FINANCIAL GROUP, INC. (NASDAQGS: MOFG) TO NICOLET BANKSHARES, INC. (NYSE: NIC). UNDER THE TERMS OF THE PROPOSED TRANSACTION, SHAREHOLDERS OF MIDWESTONE WILL RECEIVE 2.6 SHARES OF FARMERS COMMON STOCK FOR EACH SHARE OF MIDWESTONE THAT THEY OWN. KSF IS SEEKING TO DETERMINE WHETHER THIS CONS.
MOFG
• Oct. 25, 2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (“KSF”) ARE INVESTIGATING THE PROPOSED SALE OF ADVERUM BIOTECHNOLOGIES, INC. (NASDAQCM: ADVM) TO ELI LILLY AND COMPANY (NYSE: LLY). UNDER THE TERMS OF THE PROPOSED TRANSACTION, SHAREHOLDERS OF ADVERUM WILL RECEIVE $3.56 PER SHARE IN CASH PLUS ONE NON-TRANSFERABLE CONTINGENT VALUE RIGHT (CVR) ENTITLING THE HOLDER TO RECEIVE UP TO AN ADDITIONAL $8.
LLY
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF KBR, INC. (NYSE: KBR) BETWEEN MAY 6, 2025 AND JUNE 19, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 18, 2025 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION FIRST FILED BY THE FIRM.
KBR
• Oct. 25, 2025
CLN-978 LED TO RAPID AND DEEP B CELL DEPLETION IN VITRO AND IN VIVO IN MULTIPLE AUTOIMMUNE DISEASES CAMBRIDGE, MASS., OCT. 25, 2025 (GLOBE NEWSWIRE) -- CULLINAN THERAPEUTICS, INC. (NASDAQ: CGEM), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY ACCELERATING POTENTIAL FIRST- OR BEST-IN-CLASS, HIGH-IMPACT THERAPIES IN AUTOIMMUNE DISEASES AND CANCER, WILL PRESENT NEW PRECLINICAL DATA FOR CLN-978, ITS NOVEL INVESTIGATIONAL CD19XCD3 BISPECIFIC T CELL ENGAGER.
CGEM
• Oct. 25, 2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ACR25--BMS PRESENTS ENCOURAGING DATA FROM PHASE 1 BREAKFREE-1 STUDY OF CD19 NEX-T™ CAR T CELL THERAPY IN THREE CHRONIC AUTOIMMUNE DISEASES AT ACR.
NEX
• Oct. 25, 2025
KYV-101 RESULTED IN A PROFOUND REDUCTION IN DISEASE-ASSOCIATED AUTOANTIBODIES AND IMPACT ON DISEASE ACTIVITY IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS (RA)
ACR
• Oct. 25, 2025
BASEL, OCTOBER 25, 2025 – NOVARTIS ANNOUNCED TODAY PLANS TO PRESENT DATA FROM 27 COMPANY- OR INVESTIGATOR-SPONSORED ABSTRACTS ACROSS ITS IMMUNOLOGY PORTFOLIO AND PIPELINE AT THE 2025 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CONVERGENCE. DATA TO BE PRESENTED INCLUDE LATE-BREAKING PIVOTAL PHASE III RESULTS FROM THE REPLICATE NEPTUNUS-1 AND NEPTUNUS-2 TRIALS EVALUATING IANALUMAB IN SJÖGREN'S DISEASE1. NEW BIOMARKER DATA FROM AN ONGOING PHASE 1/2 STUDY OF RAPCABTAGENE AUTOLEUCEL IN SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS WILL ALSO BE PRESENTED, ALONG WITH COSENTYX DATA IN MULTIPLE RHEUMATOLOGY INDICATIONS2,3. “OUR DATA AT THIS YEAR'S ACR DEMONSTRATE THAT NOVARTIS IS AT THE FOREFRONT OF SCIENTIFIC INNOVATION AND IS DEVELOPING MEDICINES FOR SOME OF THE MOST CHALLENGING AUTOIMMUNE DISEASES, SUCH AS SJÖGREN'S,” SAID ANGELIKA JAHREIS, GLOBAL HEAD, DEVELOPMENT, IMMUNOLOGY, NOVARTIS. “AUTOIMMUNE DISEASES ARE OFTEN DEVASTATING AND LIFE-LIMITING. WE ARE COMMITTED TO DEVELOPING NEW THERAPIES WITH THE POTENTIAL TO TRANSFORM THE STANDARD OF CARE FOR THE MILLIONS WHO CONTINUE TO SUFFER FROM RHEUMATIC DISEASES.” IANALUMAB IS AN INVESTIGATIONAL MEDICINE THAT HAS THE POTENTIAL TO BECOME THE FIRST TARGETED THERAPY FOR SJÖGREN'S DISEASE, AN AREA OF HIGH UNMET NEED WITH NO FDA-APPROVED TREATMENTS4,5. SJÖGREN'S DISEASE AFFECTS MILLIONS OF PEOPLE GLOBALLY AND IS THE SECOND MOST PREVALENT RHEUMATIC DISEASE6. ADDITIONAL PRESENTATIONS INCLUDE DATA FOR RAPCABTAGENE AUTOLEUCEL, A NOVEL ONE-TIME INVESTIGATIONAL CAR-T CELL THERAPY BEING EVALUATED ACROSS SEVERAL REFRACTORY AUTOIMMUNE DISEASE FOR ITS POTENTIAL TO INDUCE AN IMMUNE RESET7 -9. FURTHER PRESENTATIONS WILL FEATURE REAL-WORLD DATA ON COSENTYX® (SECUKINUMAB) IN PSORIATIC ARTHRITIS, AND NEW INSIGHTS INTO THE DUAL MODE OF ACTION OF IANALUMAB. INVESTOR CALL ON NOVARTIS IMMUNOLOGY PIPELINE FOLLOWING THE CONCLUSION OF ACR, NOVARTIS WILL HOST A CONFERENCE CALL FOR INVESTORS TO PROVIDE UPDATES ON THE COMPANY'S IMMUNOLOGY PIPELINE ON THURSDAY, OCTOBER 30, 2025, AT 11:30 A.M. ET. DETAILS CAN BE FOUND HERE. KEY ABSTRACTS ACCEPTED BY ACR INCLUDE:
NVS
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN QUANEX (NYSE:NX) TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN QUANEX BETWEEN DECEMBER 12, 2024 AND SEPTEMBER 5, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL BRAGAR EAGEL & SQUIRE PARTNER BRANDON WALKER OR MARION PASSMORE DIRECTLY AT (212) 355-4648.
NX
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN CYTOKINETICS ( CYTK ) TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED COMMON STOCK IN CYTOKINETICS BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL BRAGAR EAGEL & SQUIRE PARTNER BRANDON WALKER OR MARION PASSMORE DIRECTLY AT (212) 355-4648.
CYTK
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN FLUOR (FLR) TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED FLUOR SECURITIES BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL BRAGAR EAGEL & SQUIRE PARTNER BRANDON WALKER OR MARION PASSMORE DIRECTLY AT (212) 355-4648.
FLR
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN V.F.
VFC
• Oct. 25, 2025
REVENUES OF INR 10,533 MILLION. EBITDA OF INR 2,361 MILLION.
SIFY
• Oct. 25, 2025
DEFENDANTS ALLEGEDLY HID PYLARIFY'S WEAKENING COMPETITIVE POSITION AND RISKS FROM A 2025 PRICE HIKE, MAKING LANTHEUS'S BUSINESS STATEMENTS MISLEADING.
LNTH
• Oct. 25, 2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER BRANDON WALKER ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN QUANTUM (QMCO) TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN QUANTUM BETWEEN NOVEMBER 15, 2024, AND AUGUST 18, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL BRAGAR EAGEL & SQUIRE PARTNER BRANDON WALKER OR MARION PASSMORE DIRECTLY AT (212) 355-4648.
QMCO
• Oct. 25, 2025
NEW YORK , OCT. 25, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF TELIX PHARMACEUTICALS LTD. (NASDAQ: TLX) RESULTING FROM ALLEGATIONS THAT TELIX MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
TLX
• Oct. 25, 2025
FLORHAM PARK, N.J., OCT. 25, 2025 (GLOBE NEWSWIRE) -- PHATHOM PHARMACEUTICALS, INC. (NASDAQ: PHAT), A BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING AND COMMERCIALIZING NOVEL TREATMENTS FOR GASTROINTESTINAL (GI) DISEASES, TODAY ANNOUNCED THAT RESULTS OF ADDITIONAL ANALYSES FROM ITS PIVOTAL PHASE 3 PHALCON-NERD-301 TRIAL EVALUATING VOQUEZNA® (VONOPRAZAN) TABLETS IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE (NERD) HAVE BEEN PUBLISHED IN THE AMERICAN JOURNAL OF GASTROENTEROLOGY. THE ARTICLE, TITLED “VONOPRAZAN IMPROVES NOCTURNAL GASTROESOPHAGEAL REFLUX SYMPTOMS IN NON-EROSIVE REFLUX DISEASE”, UNDERSCORES THE SIGNIFICANT BURDEN OF NIGHTTIME GERD SYMPTOMS AND THE POTENTIAL ROLE OF VOQUEZNA IN ADDRESSING THIS ASPECT OF THE DISEASE.
NERD
• Oct. 25, 2025
NEW YORK, OCT. 25, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF V.F. CORPORATION (NYSE: VFC) BETWEEN OCTOBER 30, 2023 AND MAY 20, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 12, 2025 LEAD PLAINTIFF DEADLINE.
LAW
• Oct. 25, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MAREX GROUP PLC ("MAREX" OR THE "COMPANY") (NASDAQGS: MRX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 16, 2024 AND AUGUST 5, 2025, INCLUSIVE (THE "CLASS PERIOD").
MRX
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST WPP PLC (NYSE: WPP), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SHARES BETWEEN FEBRUARY 27, 2025 AND JULY 8, 2025, INCLUSIVE (THE "CLASS PERIOD").
WPP
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 18, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST KBR, INC. (NYSE: KBR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 6, 2025 AND JUNE 19, 2025, INCLUSIVE (THE "CLASS PERIOD").
KBR
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 2, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MOLINA HEALTHCARE, INC. ("MOLINA" OR THE "COMPANY") (NYSE: MOH), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 5, 2025 AND JULY 23, 2025, INCLUSIVE (THE "CLASS PERIOD").
MOH
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 17, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST CYTOKINETICS, INCORPORATED (NASDAQGS: CYTK), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, INCLUSIVE (THE "CLASS PERIOD").
CYTK
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 14, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST FLUOR CORPORATION (NYSE: FLR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, INCLUSIVE (THE "CLASS PERIOD").
FLR
• Oct. 24, 2025
NEW YORK AND NEW ORLEANS , OCT. 24, 2025 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 12, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST V.F.
VFC
• Oct. 24, 2025
NEW YORK, NY, OCT. 24, 2025 (GLOBE NEWSWIRE) -- HARVARD AVE ACQUISITION CORPORATION (NASDAQ: HAVAU) (THE “COMPANY”) ANNOUNCED TODAY THE CLOSING OF ITS INITIAL PUBLIC OFFERING OF 14,500,000 UNITS AT $10.00 PER UNIT. THE GROSS PROCEEDS FROM THE OFFERING WERE $145 MILLION BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND ESTIMATED OFFERING EXPENSES. THE UNITS WERE LISTED ON THE NASDAQ GLOBAL MARKET (“NASDAQ”) AND BEGAN TRADING UNDER THE TICKER SYMBOL “HAVAU” ON OCTOBER 23, 2025. EACH UNIT CONSISTS OF ONE CLASS A ORDINARY SHARE AND ONE RIGHT TO RECEIVE ONE-TENTH OF ONE CLASS A ORDINARY SHARE. ONCE THE SECURITIES COMPRISING THE UNITS BEGIN SEPARATE TRADING, THE CLASS A ORDINARY SHARES AND RIGHTS ARE EXPECTED TO BE LISTED ON NASDAQ UNDER THE SYMBOLS “HAVA” AND “HAVAR”, RESPECTIVELY.
HAVAU
• Oct. 24, 2025
NORTH VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - LION ONE METALS LIMITED (TSXV: LIO) (OTCQX: LOMLF) ("LION ONE" OR THE "COMPANY") IS PLEASED TO ANNOUNCE IT HAS ENGAGED THE SERVICES OF ATRIUM RESEARCH CORPORATION ("ATRIUM"), A LEADING COMPANY SPONSORED RESEARCH FIRM. ATRIUM WILL PUBLISH VARIOUS RESEARCH REPORTS ON LION ONE BASED ON PUBLICLY AVAILABLE INFORMATION, INDUSTRY DATA, AND DISCUSSIONS WITH MANAGEMENT.
LGHL
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ENCOMPASS HEALTH CORPORATION (NYSE: EHC) RESULTING FROM ALLEGATIONS THAT ENCOMPASS HEALTH MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC. SO WHAT: IF YOU PURCHASED ENCOMPASS HEALTH SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
EHC
• Oct. 24, 2025
SAN DIEGO , OCT. 24, 2025 /PRNEWSWIRE/ -- ROBBINS GELLER RUDMAN & DOWD LLP IS INVESTIGATING POTENTIAL VIOLATIONS OF U.S. FEDERAL SECURITIES LAWS INVOLVING NETFLIX, INC. (NASDAQ: NFLX). IF YOU HAVE INFORMATION THAT COULD ASSIST IN THE NETFLIX INVESTIGATION OR IF YOU ARE A NETFLIX INVESTOR WHO SUFFERED A LOSS AND WOULD LIKE TO LEARN MORE, YOU CAN PROVIDE YOUR INFORMATION HERE: HTTPS://WWW.RGRDLAW.COM/CASES-NETFLIX-INC-INVESTIGATION-NFLX.HTML/ YOU CAN ALSO CONTACT ATTORNEYS J.C.
NFLX
• Oct. 24, 2025
TAIPEI, TAIWAN., OCT. 24, 2025 (GLOBE NEWSWIRE) -- MILUNA ACQUISITION CORP (NASDAQ: MMTXU) (THE “COMPANY”), A CAYMAN ISLANDS EXEMPTED COMPANY, ANNOUNCED TODAY THE CLOSING OF ITS INITIAL PUBLIC OFFERING OF 6,000,000 UNITS AT $10.00 PER UNIT.
MMTXU
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA, OCT. 24, 2025 (GLOBE NEWSWIRE) -- MUSTANG ENERGY CORP. (CSE: MEC, OTC:MECPF, FRA:92T) (THE “COMPANY” OR “MUSTANG”) ANNOUNCES THAT THE NOTICE OF MEETING, INFORMATION CIRCULAR, FINANCIAL STATEMENT REQUEST FORM AND PROXY FORM (THE “MEETING MATERIALS”) FOR THE COMPANY'S UPCOMING ANNUAL GENERAL AND SPECIAL MEETING (THE “MEETING”) TO BE HELD ON NOVEMBER 14, 2025 AT SUITE 2501 – 550 BURRARD STREET, VANCOUVER, BC, CANADA AT 10:00 AM PST HAVE BEEN MAILED AND ARE POSTED AND ACCESSIBLE ON THE COMPANY'S SEDAR+ PROFILE AT WWW.SEDARPLUS.CA AND ON THE COMPANY'S WEBSITE AT HTTPS://WWW.MUSTANGENERGY.CA/ABOUT. SHAREHOLDERS CAN REQUEST A COPY OF THE AGM MATERIALS BY EMAIL AT [email protected] OR BY CALLING 604.428.7050.
MECPF
• Oct. 24, 2025
NEWS RELEASE HIGHLIGHTS: BATTERY X REBALANCING TECHNOLOGIES INC., A WHOLLY-OWNED SUBSIDIARY OF BATTERY X METALS INC., COMPLETED A FOLLOW-UP VALIDATION ASSESSMENT ON A PREVIOUSLY REBALANCED ELECTRIC TRUCK (AS DEFINED HEREIN), CONFIRMING STABLE RANGE PERFORMANCE AND DURABILITY AFTER APPROXIMATELY FOUR MONTHS AND MORE THAN 2,000 KM OF REAL-WORLD OPERATION. THE VALIDATION ASSESSMENT VERIFIED THAT THE ELECTRIC TRUCK CONTINUES TO PERFORM WITHIN THE PARAMETERS OF ITS PREVIOUSLY REPORTED INITIAL PERFORMANCE TRIAL ESTIMATED RANGE OF APPROXIMATELY 265 KM, WHILE ACHIEVING A SUSTAINED AN ESTIMATED DRIVING RANGE OF APPROXIMATELY 250 KILOMETERS DURING TRIAL 1 (AS DEFINED HEREIN) AND A VALIDATION ASSESSMENT EFFECTIVE DRIVING RANGE (AS DEFINED HEREIN) OF APPROXIMATELY 220 KM PER FULL CHARGE, MAINTAINED AFTER MORE THAN 2,000 KM OF CONTINUED USE.
BATXF
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - SIXTY NORTH GOLD MINING LTD. (CSE: SXTY) (FSE: 2F40) (OTC PINK: SXNTF) (THE "COMPANY" OR "SIXTY NORTH GOLD") ANNOUNCES THAT THAT IT HAS ARRANGED DEBT SETTLEMENTS WITH CERTAIN OFFICERS AND DIRECTORS OF THE COMPANY TO SETTLE A TOTAL OF $105,000 IN INDEBTEDNESS FOR ACCRUED MANAGEMENT AND CONSULTING FEES FROM THE PERIOD MARCH 1, 2025 TO SEPTEMBER 30, 2025, TO BE SETTLED BY THE ISSUANCE AND DELIVERY OF A TOTAL OF 954,543 COMMON SHARES OF THE COMPANY AT A DEEMED VALUE OF $0.11 PER SHARE.
SXNTF
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF SAVARA INC. (NASDAQ: SVRA) BETWEEN MARCH 7, 2024 AND MAY 23, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 7, 2025 LEAD PLAINTIFF DEADLINE.
SVRA
• Oct. 24, 2025
SANTA BARBARA, CA / ACCESS NEWSWIRE / OCTOBER 24, 2025 / AMERICAN RIVIERA BANCORP ("COMPANY") (OTCQX:ARBV), HOLDING COMPANY OF AMERICAN RIVIERA BANK ("BANK"), ANNOUNCED TODAY UNAUDITED NET INCOME OF $7.9 MILLION ($1.38 PER SHARE) FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025, COMPARED TO $6.7 MILLION ($1.15 PER SHARE) EARNED IN THE SAME REPORTING PERIOD IN THE PREVIOUS YEAR. UNAUDITED NET INCOME WAS $2.9 MILLION ($0.51 PER SHARE) FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025, COMPARED TO $2.6 MILLION ($0.46 PER SHARE) IN THE PREVIOUS QUARTER, AND $2.1 MILLION ($0.36 PER SHARE) EARNED IN THE SAME REPORTING PERIOD IN THE PREVIOUS YEAR.
ARBV
• Oct. 24, 2025
NEW YORK, NY, OCT. 24, 2025 (GLOBE NEWSWIRE) -- AT THE CAPITAL LINK WE ANNOUNCED AN INVESTIGATION INTO REVIEWING THE PUBLIC RECORD OF LUXURBAN HOTELS INC. (THE “DEBTOR”) BEFORE THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, WE THINK THE FOLLOWING CLARIFICATION CONCERNING BISNOW'S DEPUTY DIP ETHAN ROTHSTEIN'S ARTICLE DATED OCTOBER 23, 2025, TITLED “LUXURBAN HOTELS TO LIQUIDATE AS BANKRUPTCY CLAIMS SURPASS $123 MILLION.”
LUXH
• Oct. 24, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
LNG
• Oct. 24, 2025
BUENOS AIRES, ARGENTINA / ACCESS NEWSWIRE / OCTOBER 24, 2025 / CABLEVISIÓN HOLDING S.A. (BYMA:CVH)(OTC PINK:CVHSY) WILL HOST A WEBCAST PRESENTATION ON WEDNESDAY, NOVEMBER 12, 2025 AT 1:00 P.M.
CVHSY
• Oct. 24, 2025
FUNDS TO BOLSTER BITCOIN TREASURY HOLDINGS AND ADVANCE DIGITAL ASSET INITIATIVES VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - UNIVERSAL DIGITAL INC. (CSE: LFG) (FSE: 8R20) (OTCQB: LFGMF) (THE "COMPANY") IS PLEASED TO ANNOUNCE THE COMPANY HAS ENTERED INTO A SUBSCRIPTION AGREEMENT (THE "SUBSCRIPTION AGREEMENT") WITH HELENA GLOBAL INVESTMENT OPPORTUNITIES 1 LTD. ("HELENA"), PURSUANT TO WHICH THE COMPANY AGREED TO SELL AND ISSUE TO HELENA (THE "PRIVATE PLACEMENT") UP TO $50,000,000 IN AGGREGATE PRINCIPAL AMOUNT OF SENIOR SECURED CONVERTIBLE DEBENTURES (THE "CONVERTIBLE DEBENTURES").
UVV
• Oct. 24, 2025
TORONTO, ONTARIO--(NEWSFILE CORP. - OCTOBER 24, 2025) - HEALWELL AI INC. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" OR THE "COMPANY"), A HEALTHCARE ARTIFICIAL INTELLIGENCE COMPANY FOCUSED ON PREVENTATIVE CARE, ANNOUNCES IT HAS FILED AN AMENDED AND RESTATED BUSINESS ACQUISITION REPORT DATED OCTOBER 24, 2025 (THE "AMENDED BAR"), RELATING TO HEALWELL'S ACQUISITION OF ORION HEALTH HOLDINGS LIMITED WHICH CLOSED ON APRIL 1, 2025. THE AMENDED BAR REPLACES AND SUPERSEDES THE PREVIOUS BUSINESS ACQUISITION REPORT OF HEALWELL FILED ON JUNE 30, 2025.
HWAIF
• Oct. 24, 2025
PASCAGOULA, MISS.--(BUSINESS WIRE)--MERCHANTS & MARINE BANCORP, INC. TO ACQUIRE FARMERS-MERCHANTS BANK & TRUST.
MNMB
• Oct. 24, 2025
VANCOUVER, BC , OCT. 24, 2025 (GLOBE NEWSWIRE) -- HUMANOID GLOBAL HOLDINGS CORP. (“HUMANOID GLOBAL” OR THE “COMPANY”) ( CSE:ROBO , FWB:0XM1 , OTCQB:RBOHF ), A PUBLICLY TRADED INVESTMENT ISSUER FOCUSED ON BUILDING AND ACCELERATING A PORTFOLIO OF PIONEERING COMPANIES IN THE HUMANOID ROBOTICS AND EMBODIED AI SECTOR, IS PLEASED TO ANNOUNCE, FURTHER TO ITS NEWS RELEASE OF OCTOBER 14, 2025, THAT THE COMPANY HAS COMPLETED ITS PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS (THE “SPECIAL WARRANTS”) AT A PRICE OF $0.80 PER SPECIAL WARRANT (THE “OFFERING”). THE COMPANY ISSUED 2,500,000 SPECIAL WARRANTS AT A PRICE OF $0.80 PER SPECIAL WARRANT FOR GROSS PROCEEDS OF $2,000,000.
TRMNF
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - UNIVERSAL DIGITAL INC. (CSE: LFG) (FSE: 8R20) (OTCQB: LFGMF) (THE "COMPANY") ANNOUNCES THAT IT HAS ENTERED INTO A MARKETING SERVICES AGREEMENT WITH PLUTUS INVEST & CONSULTING GMBH ("PLUTUS"), A DIGITAL-MEDIA AND INVESTOR-RELATIONS FIRM BASED IN BREMEN, GERMANY, TO ADVANCE THE COMPANY'S INVESTOR AWARENESS AND DIGITAL MARKETING STRATEGY ACROSS EUROPEAN AND INTERNATIONAL MARKETS. ON OCTOBER 24, 2025, THE COMPANY ENTERED INTO A THREE-MONTH AGREEMENT WITH PLUTUS COMMENCING NOVEMBER 1, 2025 AND ENDING JANUARY 31, 2026.
UVV
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF CYTOKINETICS, INC. (NASDAQ: CYTK) BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 17, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED CYTOKINETICS COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
CYTK
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF FLUOR CORPORATION (NYSE: FLR) BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 14, 2025 LEAD PLAINTIFF DEADLINE.
FLR
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF FLUOR CORPORATION (NYSE: FLR) BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 14, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED FLUOR SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
FLR
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - LODESTAR METALS CORP. (TSXV: LSTR) (OTCQB: SVTNF) ("LODESTAR" OR THE "COMPANY") ANNOUNCES THAT IT HAS CLOSED THE FIRST TRANCHE OF ITS PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT FINANCING (THE "OFFERING") (SEE NEWS RELEASES DATED SEPTEMBER 29, 2025, OCTOBER 15, 2025 AND OCTOBER 22, 2025) BY ISSUING 14,982,068 UNITS OF THE COMPANY (THE "UNITS") AT A PRICE OF $0.075 PER UNIT FOR GROSS PROCEEDS OF $1,123,655.10 (THE "FIRST TRANCHE"). EACH UNIT IS COMPRISED OF ONE (1) COMMON SHARE OF THE COMPANY (A "SHARE) AND ONE-HALF OF ONE (1/2) SHARE PURCHASE WARRANT (EACH WHOLE SHARE PURCHASE WARRANT, A "UNIT WARRANT"), WITH EACH UNIT WARRANT ENTITLING THE HOLDER TO PURCHASE ONE ADDITIONAL SHARE (A "UNIT WARRANT SHARE") AT A PRICE OF $0.12 PER UNIT WARRANT SHARE FOR A PERIOD OF TWO YEARS FROM THE DATE OF ISSUE (THE "EXPIRY DATE").
UNTC
• Oct. 24, 2025
NIPOCALIMAB, A FIRST-IN-CLASS FCRN BLOCKER BEING INVESTIGATED FOR SJD, MET ITS PRIMARY ENDPOINT IN THE PHASE 2 DAHLIAS STUDY WITH STATISTICALLY SIGNIFICANT IMPROVEMENT IN CLINESSDAI SCORE , WHICH IS BASED ON 11 KEY SYSTEMIC DISEASE DOMAINS, AT WEEK 24 VERSUS PLACEBO CRITICAL PATIENT-REPORTED SJD SYMPTOMS INCLUDING DRYNESS, PAIN AND FATIGUE TRENDED TOWARDS GREATER IMPROVEMENT IN THE NIPOCALIMAB-TREATED GROUP COMPARED TO PLACEBO-TREATED PATIENTS NIPOCALIMAB IS THE ONLY INVESTIGATIONAL TREATMENT TO BE GRANTED BREAKTHROUGH THERAPY DESIGNATION (BTD) BY U.S. FDA FOR THE TREATMENT OF ADULTS LIVING WITH MODERATE-TO-SEVERE SJD, AND THE PHASE 3 DAFFODIL STUDY IS CURRENTLY ENROLLING PATIENTS SPRING HOUSE, PA. , OCT. 24, 2025 /PRNEWSWIRE/ -- JOHNSON & JOHNSON (NYSE: JNJ) TODAY ANNOUNCED FINDINGS FROM THE PHASE 2 DAHLIAS STUDY PUBLISHED IN THE LANCET SHOWING THAT NIPOCALIMAB, AN INVESTIGATIONAL FCRN TREATMENT FOR SJÖGREN'S DISEASE (SJD), SIGNIFICANTLY DECREASED DISEASE ACTIVITY AND SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE DISEASE.1 THE STUDY MET ITS PRIMARY ENDPOINT, WITH STATISTICALLY SIGNIFICANT IMPROVEMENT IN CLINESSDAI A SCORE, A KEY SJD ACTIVITY INDEX, AT WEEK 24 IN THE NIPOCALIMAB 15 MG/KG Q2W GROUP COMPARED TO PLACEBOB.1 REDUCTIONS IN DISEASE ACTIVITY WERE SUPPORTED BY FAVORABLE CHANGES IN KEY BIOMARKERS WHEN COMPARED TO PLACEBO, INCLUDING LOWER LEVELS OF RHEUMATOID FACTOR, FEWER CIRCULATING IMMUNE COMPLEXES, AND DECREASED INFLAMMATORY MARKERS.1 THIS SIGNIFICANT REDUCTION IN DISEASE ACTIVITY SUGGESTS NIPOCALIMAB MAY LESSEN THE BURDEN OF SJD SYMPTOMS FOR PATIENTS IMPACTED BY THE CONDITION.1 PATIENTS WHO RECEIVED NIPOCALIMAB REPORTED A DECREASE IN SYMPTOMS, WITH NUMERICAL IMPROVEMENTS COMPARED WITH PLACEBO IN THE HALLMARK SYMPTOMS OF SJD INCLUDING DRYNESS OF THE MOUTH, EYES, AND/OR VAGINA, AS WELL AS FATIGUE AND JOINT PAIN.1 ADDITIONALLY, AN IMPROVEMENT IN OBJECTIVE SALIVARY FLOW (I.E.
JNJ
• Oct. 24, 2025
NEW YORK--(BUSINESS WIRE)--WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF MARINEMAX, INC. (NYSE: HZO) RESULTING FROM ALLEGATIONS THAT MARINEMAX MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC. SO WHAT: IF YOU PURCHASED MARINEMAX SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT. TH.
HZO
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF DESIGNER BRANDS INC. (NYSE: DBI) RESULTING FROM ALLEGATIONS THAT DESIGNER BRANDS MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
DBI
• Oct. 24, 2025
HONG KONG--(BUSINESS WIRE)--YUNQI CAPITAL LIMITED (TOGETHER WITH ITS AFFILIATES AND THE FUNDS IT ADVISES, “YUNQI CAPITAL”), AN INVESTMENT MANAGEMENT FIRM AND 5.1% SHAREHOLDER OF STAAR SURGICAL COMPANY (“STAAR” OR THE “COMPANY”) (NASDAQ:STAA), TODAY RELEASED THE FOLLOWING LETTER TO THE BOARD OF DIRECTORS OF STAAR AFTER THE DECISION BY STAAR SURGICAL AND ALCON INC. (SIX/NYSE:ALC) TO ADJOURN STAAR'S SPECIAL MEETING OF STOCKHOLDERS TO VOTE ON THE PROPOSED SALE TO ALCON ON THE TERMS ANNOUNCED ON AUG.
ALC
• Oct. 24, 2025
NEW YORK--(BUSINESS WIRE)--WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF TVARDI THERAPEUTICS, INC. (NASDAQ: TVRD) RESULTING FROM ALLEGATIONS THAT TVARDI THERAPEUTICS MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC. SO WHAT: IF YOU PURCHASED TVARDI THERAPEUTICS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH.
TVRD
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - SCOPE TECHNOLOGIES CORP. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("SCOPE TECHNOLOGIES" OR THE "COMPANY") TODAY ANNOUNCED A NON-BROKERED PRIVATE PLACEMENT FINANCING OF 7,894,737 UNITS ("UNITS") AT A PRICE OF $0.38 PER UNIT FOR GROSS PROCEEDS OF $3,000,000 (THE "OFFERING"). EACH UNIT UNDER THE OFFERING WILL CONSIST OF ONE COMMON SHARE AND ONE-HALF OF ONE SHARE PURCHASE WARRANT (EACH WHOLE WARRANT, A "WARRANT"), WITH EACH WARRANT ENTITLING THE HOLDER TO PURCHASE ONE ADDITIONAL SHARE AT A PRICE OF $0.60 PER SHARE FOR A PERIOD OF THREE YEARS FROM THE DATE OF ISSUE.
SCPE
• Oct. 24, 2025
EAGLE, IDAHO, OCT. 24, 2025 (GLOBE NEWSWIRE) -- THE PENNANT GROUP, INC. (NASDAQ: PNTG), THE PARENT COMPANY OF OPERATING SUBSIDIARIES THAT PROVIDE HOME HEALTH, HOSPICE AND SENIOR LIVING SERVICES, ANNOUNCED TODAY THAT IT EXPECTS TO ISSUE ITS THIRD QUARTER 2025 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 5, 2025.
PNTG
• Oct. 24, 2025
LED BY ERIC SPROTT AND CRESCAT CAPITAL VANCOUVER, BC / ACCESS NEWSWIRE / OCTOBER 24, 2025 / ELECTRIC METALS (USA) LIMITED ("EML" OR THE "COMPANY") (TSXV:EML)(OTCQB:EMUSF) IS PLEASED TO ANNOUNCE THE CLOSING OF ITS PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT, RAISING GROSS PROCEEDS OF APPROXIMATELY C$4 MILLION. THE FINANCING, LED BY ERIC SPROTT AND CRESCAT CAPITAL, WILL ADVANCE THE COMPANY'S NORTH STAR MANGANESE PROJECT IN MINNESOTA, SUPPORTING A CRITICAL U.S. DOMESTIC SUPPLY OF HIGH-PURITY MANGANESE PRODUCTS, INCLUDING HIGH-PURITY MANGANESE SULFATE MONOHYDRATE (HPMSM), FOR THE U.S. ELECTRIC VEHICLE BATTERY AND ENERGY SECTOR.
EML
• Oct. 24, 2025
LAS VEGAS, OCT. 24, 2025 (GLOBE NEWSWIRE) -- GBANK FINANCIAL HOLDINGS INC. (THE "COMPANY") (NASDAQ: GBFH), THE PARENT COMPANY FOR GBANK (THE "BANK"), TODAY ANNOUNCED IT HAS UPDATED THE DATE FOR THE RELEASE ITS THIRD QUARTER 2025 FINANCIAL RESULTS FROM AFTER THE MARKET CLOSES ON MONDAY, OCTOBER 27, 2025 TO AFTER THE MARKET CLOSES ON TUESDAY, OCTOBER 28, 2025. THE TIMING OF THE QUARTERLY EARNINGS CALL REMAINS UNCHANGED ON WEDNESDAY, OCTOBER 29, 2025, AT 10:00 A.M., PST. INTERESTED PARTIES CAN PARTICIPATE REMOTELY VIA INTERNET CONNECTIVITY. THERE WILL BE NO PHYSICAL LOCATION FOR ATTENDANCE.
GBFH
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF BRUNELLO CUCINELLI S.P.A (OTC: BCUCY) RESULTING FROM ALLEGATIONS THAT BRUNELLO CUCINELLI MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
BCUCY
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF FLY-E GROUP, INC. (NASDAQ: FLYE) BETWEEN JULY 15, 2025 AND AUGUST 14, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 10, 2025 LEAD PLAINTIFF DEADLINE.
FLYE
• Oct. 24, 2025
NEW EXECUTIVE LEADERSHIP, OPEN MARKET STOCK PURCHASES, AND MINIMUM EQUITY OWNERSHIP POLICY FURTHER ALIGN SHAREHOLDER INTERESTS FORTIFIED BALANCE SHEET INCLUDING RECENT PROCEEDS OF APPROXIMATELY $7.0 MILLION FROM ATM FACILITY EXTENDS CASH RUNWAY INTO 2026 SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON MONDAY, DECEMBER 15, 2025, AT 9:00 A.M. EASTERN TIME.
SCWO
• Oct. 24, 2025
VETERAN DISNEY ENTERTAINMENT ATTORNEY TO LEAD LEGAL OPERATIONS FOR LEADING TELEVISION BROADCASTING COMPANY DETROIT , OCT. 24, 2025 /PRNEWSWIRE/ -- GRAHAM MEDIA GROUP, A PROMINENT TELEVISION BROADCASTING COMPANY, TODAY ANNOUNCED THE APPOINTMENT OF MICHAEL STORM AS VICE PRESIDENT & GENERAL COUNSEL. STORM BRINGS EXTENSIVE EXPERIENCE IN MEDIA LAW, TALENT AND ENTERTAINMENT CONTRACTS, AND LABOR RELATIONS FROM HIS DISTINGUISHED CAREER AT THE WALT DISNEY COMPANY.
GHC
• Oct. 24, 2025
VANCOUVER, BC / ACCESS NEWSWIRE / OCTOBER 24, 2025 / ZIMTU CAPITAL CORP. (TSXV:ZC)(FSE:ZCT1) (THE "COMPANY" OR "ZIMTU") ANNOUNCES A WARRANT EXERCISE INCENTIVE PROGRAM (THE "INCENTIVE PROGRAM") RELATING TO OUTSTANDING COMMON SHARE PURCHASE WARRANTS (THE "ELIGIBLE WARRANTS") SET OUT IN THE TABLE BELOW. THE ELIGIBLE WARRANTS WERE ISSUED IN CONNECTION WITH PRIVATE PLACEMENTS.
ZC
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - STARCORE INTERNATIONAL MINES LTD. (TSX: SAM) ("STARCORE" OR THE "COMPANY") REPORTS THE RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS (THE "MEETING") HELD ON OCTOBER 24, 2025, AT WHICH 48.75% OF SHAREHOLDERS ENTITLED TO VOTE WERE PRESENT.
SHVLF
• Oct. 24, 2025
FRANKLIN, TENN.--(BUSINESS WIRE)--COMMUNITY HEALTH SYSTEMS, INC. (NYSE: CYH) ANNOUNCED TODAY THAT CERTAIN SUBSIDIARIES OF THE COMPANY HAVE ENTERED INTO A DEFINITIVE AGREEMENT TO SELL 186-BED REGIONAL HOSPITAL OF SCRANTON AND 122-BED MOSES TAYLOR HOSPITAL IN SCRANTON, PENNSYLVANIA, 369-BED WILKES-BARRE GENERAL HOSPITAL IN WILKES-BARRE, PENNSYLVANIA, AND CERTAIN RELATED BUSINESSES TO AFFILIATES OF TENOR HEALTH FOUNDATION. SINCE THE PREVIOUSLY ANNOUNCED DIVESTITURE TO WOODBRIDGE HEALTHCARE, INC. W.
CYH
• Oct. 24, 2025
SPRINGFIELD, MO., OCT. 24, 2025 (GLOBE NEWSWIRE) -- PAUL MUELLER COMPANY (OTC: MUEL) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS DECLARED A CASH DIVIDEND OF 30 CENTS ($0.30) PER SHARE ON ITS OUTSTANDING COMMON STOCK.
MUEL
• Oct. 24, 2025
SPRINGFIELD, MO., OCT. 24, 2025 (GLOBE NEWSWIRE) -- PAUL MUELLER COMPANY (OTC: MUEL) TODAY ANNOUNCED EARNINGS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
MUEL
• Oct. 24, 2025
SPRINGFIELD, MO., OCT. 24, 2025 (GLOBE NEWSWIRE) -- PAUL MUELLER COMPANY (OTC: MUEL) (THE “COMPANY”) TODAY ANNOUNCED THAT THE BOARD OF DIRECTORS HAS APPROVED A TENDER OFFER (THE “TENDER OFFER”) TO REPURCHASE UP TO 31,000 SHARES OF THE COMPANY'S COMMON STOCK (“SHARES”) AT A PURCHASE PRICE OF $485 PER SHARE, UP TO $15,035,000 (THE “MAXIMUM AGGREGATE PURCHASE PRICE”).
MUEL
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE "M&A CLASS ACTION FIRM"), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING ADVERUM BIOTECHNOLOGIES, INC. (NASDAQ: ADVM ) RELATED TO ITS SALE TO ELI LILLY AND COMPANY.
ADVM
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE "M&A CLASS ACTION FIRM"), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING MIDWESTONE FINANCIAL GROUP, INC. (NASDAQ: MOFG ) RELATED TO ITS SALE TO NICOLET BANKSHARES, INC. UNDER THE TERMS OF THE PROPOSED TRANSACTION, MIDWESTONE SHAREHOLDERS WILL RECEIVE 0.3175 OF A SHARE OF NICOLET COMMON STOCK FOR EACH SHARE OF MIDWESTONE COMMON STOCK.
MOFG
• Oct. 24, 2025
NEW YORK , OCT. 24, 2025 /PRNEWSWIRE/ -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE "M&A CLASS ACTION FIRM"), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING NICOLET BANKSHARES, INC. (NYSE: NIC) RELATED TO ITS MERGER WITH MIDWESTONE FINANCIAL GROUP, INC. UNDER THE TERMS OF THE PROPOSED TRANSACTION, MIDWESTONE SHAREHOLDERS WILL RECEIVE 0.3175 OF A SHARE OF NICOLET COMMON STOCK FOR EACH SHARE OF MIDWESTONE COMMON STOCK.
NIC
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF NATIONAL GRID PLC (NYSE: NGG) RESULTING FROM ALLEGATIONS THAT NATIONAL GRID PLC MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC. SO WHAT: IF YOU PURCHASED NATIONAL GRID SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
NGG
• Oct. 24, 2025
SCOTTSDALE, AZ, OCT. 24, 2025 (GLOBE NEWSWIRE) -- AMERICAN HOME WATER AND AIR, A RESIDENTIAL WATER AND AIR SYSTEMS PROVIDER HEADQUARTERED IN SCOTTSDALE, TODAY ANNOUNCED THE EXPANSION OF ITS OPERATIONAL SERVICE NETWORK ACROSS THE GREATER SCOTTSDALE REGION. THE DEVELOPMENT IS INTENDED TO STRENGTHEN THE COMPANY'S CAPACITY TO DELIVER WATER TREATMENT, REVERSE OSMOSIS, WATER SOFTENER, AC REPAIR, FURNACE REPAIR, AND HVAC MAINTENANCE SERVICES TO LOCAL HOMEOWNERS.
• Oct. 24, 2025
BLOCK & LEVITON FILED A SECURITIES FRAUD LAWSUIT AGAINST JAMES HARDIE INDUSTRIES PLC (NYSE: JHX). INVESTORS WHO LOST MONEY IN JHX SHOULD CONTACT THE FIRM.
JHX
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - SIXTY NORTH GOLD MINING LTD. (CSE: SXTY) (FSE: 2F40) (OTC PINK: SXNTF) (THE "COMPANY" OR "SIXTY NORTH GOLD") IS PLEASED TO REPORT THAT FURTHER TO ITS NEWS RELEASES OF OCTOBER 14, 2025, AND OCTOBER 22, 2025, THE COMPANY HAS NOW CLOSED ITS SECOND AND FINAL TRANCHE OF 833,333 UNITS FOR GROSS PROCEEDS OF $50,000.
SXNTF
• Oct. 24, 2025
NEW YORK--(BUSINESS WIRE)--TAMBORAN RESOURCES CORPORATION (NYSE: TBN, ASX: TBN): TAMBORAN RESOURCES CORPORATION CHAIRMAN AND INTERIM CEO, RICHARD STONEBURNER, SAID: “WE THANK OUR EXISTING SHAREHOLDERS FOR THEIR CONTINUED SUPPORT IN TAMBORAN AND WELCOME NEW SHAREHOLDERS ON OUR JOURNEY TO DELIVERING OUR WORLD CLASS SHALE GAS DEVELOPMENT OF THE BEETALOO BASIN. “THE STRATEGIC PARTNERSHIP WITH BAKER HUGHES IS AN IMPORTANT STEP IN OUR COST REDUCTION INITIATIVE ACROSS OUR OFS ACTIVITIES IN THE BEETALO.
TBN
• Oct. 24, 2025
NIAGARA-ON-THE-LAKE, ONTARIO--(NEWSFILE CORP. - OCTOBER 24, 2025) - DIAMOND ESTATES WINES & SPIRITS INC. (TSXV: DWS) ("DIAMOND ESTATES" OR THE "COMPANY") WISHES TO PROVIDE CERTAIN ADDITIONAL INFORMATION CONCERNING THE SHAREHOLDER RESOLUTION WHICH WOULD APPROVE THE ISSUANCE OF NEW REPLACEMENT DEBENTURES, INCLUDING TO 3346625 CANADA INC., AN ENTITY CONTROLLED BY MR. PIERRE-PAUL LASSONDE, AND LASSONDE INDUSTRIES INC. (THE "LASSONDE GROUP"), WHICH IS BEING CONSIDERED BY SHAREHOLDERS AT THE COMPANY'S UPCOMING ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS ON OCTOBER 30, 2025 (THE "MEETING").
DWS
• Oct. 24, 2025
NEW YORK, OCT. 24, 2025 (GLOBE NEWSWIRE) -- ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL BREACHES OF FIDUCIARY DUTIES BY THE DIRECTORS AND OFFICERS OF SEMTECH CORPORATION (NASDAQ: SMTC).
SMTC
• Oct. 24, 2025
JAKE WILLIAMSON TO HEAD SINGLE-FAMILY AND TOM KLEIN TO LEAD GENERAL COUNSEL, WITH NEARLY 40 YEARS COMBINED EXPERIENCE AT THE COMPANY WASHINGTON , OCT. 24, 2025 /PRNEWSWIRE/ -- TODAY, FANNIE MAE (OTCQB: FNMA) ANNOUNCED THE PROMOTION OF TWO LONG-TIME FANNIE MAE VETERANS TO LEAD THE SINGLE-FAMILY BUSINESS AND GENERAL COUNSEL'S OFFICE. "WE ARE PLEASED TO ANNOUNCE THE PROMOTION OF FANNIE MAE SEASONED VETERANS JAKE WILLIAMSON TO ACTING HEAD OF SINGLE-FAMILY AND TOM KLEIN TO ACTING GENERAL COUNSEL.
FNMA
• Oct. 24, 2025
HAMILTON, BERMUDA , OCT. 24, 2025 /PRNEWSWIRE/ -- BORR DRILLING LIMITED (NYSE: BORR) (THE "COMPANY") ANNOUNCES THAT IT HAS TERMINATED TWO OF ITS DRILLING CONTRACTS FOLLOWING THE RECENT IMPLEMENTATION OF INTERNATIONAL SANCTIONS AFFECTING A COUNTERPARTY. THE TERMINATIONS RELATE TO THE CONTRACTS FOR THE RIGS ODIN AND HILD IN MEXICO THAT HAD FIRM COMMITMENTS UNTIL NOVEMBER 2025 AND MARCH 2026, RESPECTIVELY.
BORR
• Oct. 24, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - OCTOBER 24, 2025) - HOMERUN RESOURCES INC. (TSXV: HMR) (OTCQB: HMRFF) ("HOMERUN" OR THE "COMPANY") ANNOUNCES THAT THE COMPANY HAS SUBMITTED ITS FORMAL APPLICATION FOR CONDITIONAL APPROVAL OF THE PREVIOUSLY ANNOUNCED $6-MILLION FINANCING WITH A SINGLE INSTITUTIONAL INVESTOR. THE COMPANY IS NOW AWAITING CONDITIONAL APPROVAL FROM THE TSX VENTURE EXCHANGE.
HMRFF
• Oct. 24, 2025
TORONTO, OCT. 24, 2025 (GLOBE NEWSWIRE) -- DISCOVERY SILVER CORP. (TSX: DSV, OTCQX: DSVSF) (“DISCOVERY” OR THE “COMPANY”) TODAY ANNOUNCED THAT THE COMPANY WILL RELEASE ITS FINANCIAL AND OPERATING RESULTS FOR THE THIRD QUARTER OF 2025 PRIOR TO THE MARKET OPEN ON THURSDAY, NOVEMBER 13, 2025. THE COMPANY WILL THEN HOST A CONFERENCE CALL TO REVIEW THE RESULTS LATER THAT DAY, AT 1:00 PM EASTERN TIME (“ET”). THOSE WISHING TO JOIN THE CALL CAN DO SO USING THE TELEPHONE NUMBERS LISTED BELOW. THE CALL WILL ALSO BE WEBCAST AND AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.DISCOVERYSILVER.COM.
DSVSF
• Oct. 24, 2025
VANCOUVER, BC / ACCESS NEWSWIRE / OCTOBER 24, 2025 / BEMETALS CORP. (TSXV:BMET)(OTCQB:BMTLF)(FRANKFURT:1OI.F) (THE "COMPANY" OR "BEMETALS") IS PLEASED TO REPORT IT HAS CLOSED ITS PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT (THE "PRIVATE PLACEMENT") BY ISSUING 12,126,284 COMMON SHARES OF THE COMPANY THAT QUALIFY AS "FLOW-THROUGH SHARES", AS DEFINED IN THE INCOME TAX ACT (CANADA) (THE "TAX ACT"), (EACH, A "FT SHARE") AT A PRICE OF $0.07 PER FT SHARE FOR AGGREGATE GROSS PROCEEDS OF C$848,840. THE COMPANY INTENDS TO USE THE GROSS PROCEEDS OF THE PRIVATE PLACEMENT TO INCUR QUALIFYING EXPENDITURES (AS DEFINED BELOW) ON THE COMPANY'S SAVANT GOLD PROJECT (THE "SAVANT PROJECT"), LOCATED IN ONTARIO, CANADA.
BMTLF
• Oct. 24, 2025
NEW YORK, NY, OCT. 24, 2025 (GLOBE NEWSWIRE) -- PHONEX HOLDINGS, INC. (OTC: PXHI) TODAY ANNOUNCES TO ITS SHAREHOLDERS THAT THE COMPANY HAS DETERMINED THAT, BASED ON ITS CURRENT UNDERSTANDING OF THE APPLICABLE PROVISIONS OF SECTION 1202 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AND SUBJECT TO THE SATISFACTION OF ALL APPLICABLE REQUIREMENTS, THE COMPANY MAY QUALIFY AS A “QUALIFIED SMALL BUSINESS” FOR PURPOSES OF THE POTENTIAL EXCLUSION OF GAIN FROM THE SALE OR EXCHANGE OF “QUALIFIED SMALL BUSINESS STOCK” (“QSBS”) UNDER SECTION 1202 OF THE CODE.
PXHI
• Oct. 24, 2025
TORONTO, ONTARIO--(NEWSFILE CORP. - OCTOBER 24, 2025) - SPARQ SYSTEMS INC. (TSXV: SPRQ) (OTCQB: SPRQF) (FSE: M26) ("SPARQ" OR THE "COMPANY") ANNOUNCES THAT IT HAS TERMINATED ITS INVESTOR RELATIONS AGREEMENT (THE "AGREEMENT") WITH JOHN WELSH. THE AGREEMENT WAS ANNOUNCED BY THE COMPANY ON JUNE 26, 2025.
SPRQF
• Oct. 24, 2025
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, THE FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL OCTOBER 28, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST DOW INC. (NYSE: DOW), IF THEY PURCHASED THE COMPANY'S SECURITIES BETWEEN JANUARY 30, 2025 AND JULY 23, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT F.
DOW
• Oct. 24, 2025
WEST HOLLYWOOD, CALIF.--(BUSINESS WIRE)--GRINDR INC. (NYSE: GRND) (“GRINDR” OR THE “COMPANY”), THE GLOBAL GAYBORHOOD IN YOUR POCKET™, TODAY CONFIRMED THAT THE SPECIAL COMMITTEE OF ITS BOARD OF DIRECTORS (THE “BOARD”) HAS RECEIVED A NON-BINDING, UNSOLICITED TAKE-PRIVATE PROPOSAL FROM LARGE SHAREHOLDERS RAY ZAGE AND JAMES LU (THE “PROPOSING SHAREHOLDERS”) TO ACQUIRE GRINDR FOR $18.00 PER SHARE IN CASH. THE PROPOSING SHAREHOLDERS, TOGETHER WITH THEIR AFFILIATED ENTITIES, CURRENTLY BENEFICIALLY OWN.
GRND
• Oct. 24, 2025
